2012-09-18 08:00:34 - Fast Market Research recommends "Erectile Dysfunction - Pipeline Review, H2 2012" from Global Markets Direct, now available

Global Markets Direct's, 'Erectile Dysfunction - Pipeline Review, H2 2012', provides an overview of the Erectile Dysfunction therapeutic pipeline. This report provides information on the therapeutic development for Erectile Dysfunction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Erectile Dysfunction. 'Erectile Dysfunction - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/463703_erectile_dysfunction_pipeline_review_ ..


Note*: Certain sections in the report may be removed or altered based

on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Erectile Dysfunction.
* A review of the Erectile Dysfunction products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Erectile Dysfunction pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Erectile Dysfunction.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Erectile Dysfunction pipeline depth and focus of Erectile Dysfunction therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Erectile Dysfunction Therapeutic Products under Development, Key Players in Erectile Dysfunction Therapeutics, Erectile Dysfunction Pipeline Overview, Erectile Dysfunction Pipeline, Erectile Dysfunction Pipeline Assessment

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Erectile Dysfunction Overview
Therapeutics Development
An Overview of Pipeline Products for Erectile Dysfunction
Erectile Dysfunction Therapeutics under Development by Companies
Erectile Dysfunction Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Erectile Dysfunction Therapeutics - Products under Development by Companies
Erectile Dysfunction Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Erectile Dysfunction Therapeutics Development
Chong Kun Dang Pharmaceutical
Dong-A Pharmaceutical Co., Ltd.
VIVUS, Inc.
Warner Chilcott Limited
Bayer AG
IntelGenx Technologies Corp.
NexMed, Inc.
NovaDel Pharma, Inc.
Palatin Technologies, Inc.
Senetek PLC
Yuhan Corporation
Futura Medical plc.
Rexahn Pharmaceuticals, Inc.
Global Health Ventures Inc.
Medisyn Technologies, Inc.
Erectile Dysfunction - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Spedra - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PL-6983 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Vitaros - Drug Profile
Product Description
Mechanism of Action
R&D Progress
KDM 1101 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zoraxel - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Duromist - Drug Profile
Product Description
Mechanism of Action
R&D Progress
phentolamine mesylate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
CKD-533 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Viagra - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Alfuzosin - Drug Profile
Product Description

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=463703&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.